UT San Antonio

Hepatitis and HIV/Hepatitis Coinfection ECHO

HIV, hepatitis B (HBV) and hepatitis C (HCV) share similar routes of transmission. Of those with HIV, approximately 6-14% also have HBV infection and 25% have HCV infection. The consequences of coinfection include quicker progression of liver disease, liver cirrhosis, end-stage liver disease and hepatocellular carcinoma. Join these sessions to learn evidence-based strategies for fighting this syndemic, connect with health professionals, and become part of the solution.

Sessions are on third Wednesdays (12-1 pm CT) of each month

Continuing Education credits for physicians, nurses, pharmacists, and pharmacist technicians are provided at no cost.

View Program Flyer »

Cases Needed!

ECHOs thrive on the contribution of all learners. If you want guidance or support, please consider presenting a case at our ECHO. Doing this is simple: just fill out a case presentation form online. Then join a session and take a few minutes to talk us through your case, your experience, and your questions for the learning network. We’ll facilitate discussion of the case and provide you with evidence-based, multidisciplinary mentorship on your next steps.

Submit a case

Upcoming Session:

Register here

Session 30 – August 19, 2026 (12-1pm CT)

  • Didactic Topic: Hepatitis C Treatment in Practice: Medications, Access and Interactions
  • Presented by: Dr.DeWayne Davidson, PharmD, BCACP, BC-ADM

Session 29 – July 15, 2026 (12-1pm CT)

  • Didactic Topic: Extra-Intestinal Manifestations of Chronic HCV Infection: Systemic Consequences Beyond the Liver
  • Presented by: Dr.Victor Ankoma-sey, MD, FACP, AASLD

Session 29 – June 17, 2026 (12-1pm CT)

  • Didactic Topic: From Blueprint to Action: Developing and Publishing the Texas Viral Hepatitis Elimination Plan
  • Presented by: Dr. Ariel C. Harrison, PhD, MPH
  • View Recordings »

Session 28 – May 20, 2026 (12-1pm CT)

  • Didactic Topic: Hepatitis A and E: Acute Hepatitis in Vulnerable Populations
  • Presented by: Dr. Stevan A. Gonzalez, MD

Session 27 – April 15, 2026 (12-1pm CT)

  • Didactic Topic: Treating HIV/HCV Coinfection: Current Therapies and Considerations
  • Presented by: Dr. Divya Chandramohan, MD
  • View Recordings »

Session 26 – March 18, 2026 (12-1pm CT)

  • Didactic Topic: Epidemiology of HIV/HCV Coinfection in the United States
  • Presented by: Dr. Ruth Serrano, MD
  • View Recordings »

Session 25 – February 18, 2026 (12-1pm CT)

  • Didactic Topic: From Start to SVR: Keeping HCV Antiviral Therapy on Track
  • Presented by: Dr. Divya Chandramohan, MD
  • View Recordings »

Session 24 – January 21, 2026 (12-1pm CT)

  • Didactic Topic: Viral Hepatitis A: Essential Clinical Insights for Providers
  • Presented by: Dr. Victor Ankoma-sey, MD, FACP, FAASLD, AASLD

Session 23 – December 17, 2025 (12-1pm CT)

  • Didactic Topic: Communicating with patients about HIV and Hepatitis: Reducing Stigma and Delivering Diagnoses Effectively
  • Presented by: Dr. Ruth Serrano Pinilla, MD
  • View Recordings »

Session 22 – November 19, 2025 (12-1pm CT)

  • Didactic Topic: Intersections of Chronic Illness: Managing Diabetes in the Landscape of Hepatitis B and C
  • Presented by: Dewayne Davidson, PharmD
  • View Recordings »

Session 21 – October 15, 2025 (12-1pm CT)

  • Didactic Topic: Transmission Risks Among Persons Who Use Drugs: HCV and HIV
  • Presented by: Stevan Gonzalez, MD
  • View Recordings »

Session 20 – September 17, 2025 (12-1pm CT)

  • Didactic Topic: Introduction to Pre-Exposure Prophylaxis (PrEP)
  • Presented by: Ruth Serrano Pinilla, MD
  • View Recordings »